Literature DB >> 25162665

Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop.

John P Bilezikian1, Maria Luisa Brandi, Richard Eastell, Shonni J Silverberg, Robert Udelsman, Claudio Marcocci, John T Potts.   

Abstract

OBJECTIVE: Asymptomatic primary hyperparathyroidism (PHPT) is routinely encountered in clinical practices of endocrinology throughout the world. This report distills an update of current information about diagnostics, clinical features, and management of this disease into a set of revised guidelines. PARTICIPANTS: Participants, representing an international constituency, with interest and expertise in various facets of asymptomatic PHPT constituted four Workshop Panels that developed key questions to be addressed. They then convened in an open 3-day conference September 19-21, 2013, in Florence, Italy, when a series of presentations and discussions addressed these questions. A smaller subcommittee, the Expert Panel, then met in closed session to reach an evidence-based consensus on how to address the questions and data that were aired in the open forum. EVIDENCE: Preceding the conference, each question was addressed by a relevant, extensive literature search. All presentations and deliberations of the Workshop Panels and the Expert Panel were based upon the latest information gleaned from this literature search. CONSENSUS PROCESS: The expert panel considered all the evidence provided by the individual Workshop Panels and then came to consensus.
CONCLUSION: In view of new findings since the last International Workshop on the Management of Asymptomatic PHPT, guidelines for management have been revised. The revised guidelines include: 1) recommendations for more extensive evaluation of the skeletal and renal systems; 2) skeletal and/or renal involvement as determined by further evaluation to become part of the guidelines for surgery; and 3) more specific guidelines for monitoring those who do not meet guidelines for parathyroid surgery. These guidelines should help endocrinologists and surgeons caring for patients with PHPT. A blueprint for future research is proposed to foster additional investigation into issues that remain uncertain or controversial.

Entities:  

Mesh:

Year:  2014        PMID: 25162665      PMCID: PMC5393490          DOI: 10.1210/jc.2014-1413

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  11 in total

Review 1.  Development and use of FRAX in osteoporosis.

Authors:  J A Kanis; E V McCloskey; H Johansson; A Oden; O Ström; F Borgström
Journal:  Osteoporos Int       Date:  2010-05-13       Impact factor: 4.507

2.  Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop.

Authors:  John P Bilezikian; Aliya A Khan; John T Potts
Journal:  J Clin Endocrinol Metab       Date:  2009-02       Impact factor: 5.958

3.  Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline.

Authors:  Michael F Holick; Neil C Binkley; Heike A Bischoff-Ferrari; Catherine M Gordon; David A Hanley; Robert P Heaney; M Hassan Murad; Connie M Weaver
Journal:  J Clin Endocrinol Metab       Date:  2011-06-06       Impact factor: 5.958

4.  Vitamin D repletion in patients with primary hyperparathyroidism and coexistent vitamin D insufficiency.

Authors:  Andrew Grey; Jenny Lucas; Anne Horne; Greg Gamble; James S Davidson; Ian R Reid
Journal:  J Clin Endocrinol Metab       Date:  2005-01-11       Impact factor: 5.958

5.  The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years.

Authors:  Mishaela R Rubin; John P Bilezikian; Donald J McMahon; Thomas Jacobs; Elizabeth Shane; Ethel Siris; Julia Udesky; Shonni J Silverberg
Journal:  J Clin Endocrinol Metab       Date:  2008-06-10       Impact factor: 5.958

6.  Medical management of primary hyperparathyroidism: proceedings of the fourth International Workshop on the Management of Asymptomatic Primary Hyperparathyroidism.

Authors:  Claudio Marcocci; Jens Bollerslev; Aliya Aziz Khan; Dolores Marie Shoback
Journal:  J Clin Endocrinol Metab       Date:  2014-08-27       Impact factor: 5.958

7.  The surgical management of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop.

Authors:  Robert Udelsman; Göran Åkerström; Carlo Biagini; Quan-Yang Duh; Paolo Miccoli; Bruno Niederle; Francesco Tonelli
Journal:  J Clin Endocrinol Metab       Date:  2014-08-27       Impact factor: 5.958

8.  Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop.

Authors:  Shonni J Silverberg; Bart L Clarke; Munro Peacock; Francisco Bandeira; Stephanie Boutroy; Natalie E Cusano; David Dempster; E Michael Lewiecki; Jian-Min Liu; Salvatore Minisola; Lars Rejnmark; Barbara C Silva; Marcella D Walker; John P Bilezikian
Journal:  J Clin Endocrinol Metab       Date:  2014-08-27       Impact factor: 5.958

9.  The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know.

Authors:  A Catharine Ross; JoAnn E Manson; Steven A Abrams; John F Aloia; Patsy M Brannon; Steven K Clinton; Ramon A Durazo-Arvizu; J Christopher Gallagher; Richard L Gallo; Glenville Jones; Christopher S Kovacs; Susan T Mayne; Clifford J Rosen; Sue A Shapses
Journal:  J Clin Endocrinol Metab       Date:  2010-11-29       Impact factor: 5.958

10.  Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop.

Authors:  Richard Eastell; Maria Luisa Brandi; Aline G Costa; Pierre D'Amour; Dolores M Shoback; Rajesh V Thakker
Journal:  J Clin Endocrinol Metab       Date:  2014-08-27       Impact factor: 5.958

View more
  245 in total

Review 1.  Minimally invasive parathyroid surgery.

Authors:  Salem I Noureldine; Zhen Gooi; Ralph P Tufano
Journal:  Gland Surg       Date:  2015-10

2.  Just hypercalcaemia or acute ST elevation myocardial infarction? A review of hypercalcaemia-related electrocardiographic changes.

Authors:  Soumya Patnaik; Yu Kuang Lai
Journal:  BMJ Case Rep       Date:  2015-10-21

3.  Compliance with recommendations on surgery for primary hyperparathyroidism-from guidelines to real practice: results from an Iberian survey.

Authors:  Jesús Villar-Del-Moral; João Capela-Costa; Antonio Jiménez-García; Antonio Sitges-Serra; Daniel Casanova-Rituerto; José Rocha; Juan Manuel Martos-Martínez; Aitor de la Quintana-Basarrate; Jorge Rosa-Santos; Xavier Guirao-Garriga; José Miguel Bravo-de-Lifante; Óscar Vidal-Pérez; Antonio Moral-Duarte; José Polónia
Journal:  Langenbecks Arch Surg       Date:  2015-12-19       Impact factor: 3.445

Review 4.  Selective venous sampling for primary hyperparathyroidism: how to perform an examination and interpret the results with reference to thyroid vein anatomy.

Authors:  Takayuki Yamada; Masaya Ikuno; Yasumoto Shinjo; Atsushi Hiroishi; Shoichiro Matsushita; Tsuyoshi Morimoto; Reiko Kumano; Kunihiro Yagihashi; Takuyuki Katabami
Journal:  Jpn J Radiol       Date:  2017-06-21       Impact factor: 2.374

5.  Classic Primary Hyperparathyroidism Versus Normocalcemic and Normohormonal Variants: Do They Really Differ?

Authors:  Andreas Kiriakopoulos; Athanasios Petralias; Dimitrios Linos
Journal:  World J Surg       Date:  2018-04       Impact factor: 3.352

6.  Head-to-head comparison among 18F-choline PET/CT, 4D contrast-enhanced CT, and 18F-choline PET/4D contrast-enhanced CT in the detection of hyperfunctioning parathyroid glands: a systematic review and meta-analysis.

Authors:  Arnoldo Piccardo; Gianluca Bottoni; Luis Alejandro Boccalatte; Chiara Camponovo; Martina Musumeci; Lorenzo Bacigalupo; Carlos Collaud; Martina Ugolini; Francesco Fiz; Pierpaolo Trimboli
Journal:  Endocrine       Date:  2021-06-25       Impact factor: 3.633

Review 7.  Diagnostic imaging of osteoporosis and sarcopenia: a narrative review.

Authors:  Carmelo Messina; Gabriele Maffi; Jacopo Antonino Vitale; Fabio Massimo Ulivieri; Giuseppe Guglielmi; Luca Maria Sconfienza
Journal:  Quant Imaging Med Surg       Date:  2018-02

8.  Is parathyroidectomy safe and effective in patients with normocalcemic primary hyperparathyroidism?

Authors:  Emanuela Traini; Rocco Bellantone; Serena Elisa Tempera; Salvatore Russo; Carmela De Crea; Celestino Pio Lombardi; Marco Raffaelli
Journal:  Langenbecks Arch Surg       Date:  2018-03-14       Impact factor: 3.445

9.  Actual role of color-doppler high-resolution neck ultrasonography in primary hyperparathyroidism: a clinical review and an observational study with a comparison of 99mTc-sestamibi parathyroid scintigraphy.

Authors:  Giovanni Mariano Vitetta; Alberto Ravera; Giovanni Mensa; Luca Fuso; Pierluigi Neri; Alessandro Carriero; Stefano Cirillo
Journal:  J Ultrasound       Date:  2018-10-24

Review 10.  Comparative efficacy of parathyroidectomy and active surveillance in patients with mild primary hyperparathyroidism: a systematic review and meta-analysis.

Authors:  N Singh Ospina; S Maraka; R Rodriguez-Gutierrez; A E Espinosa de Ycaza; S Jasim; M Gionfriddo; A Castaneda-Guarderas; J P Brito; A Al Nofal; P Erwin; R Wermers; V Montori
Journal:  Osteoporos Int       Date:  2016-08-25       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.